The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.

Published Date: 08 Dec 2023

At three years, 25% of patients with high-risk, BCG-unresponsive disease had no recurrences.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early, virtual palliative care feasible for advanced lung cancer

2.

Financial hardship common in patients with cancer

3.

Breast cancer prevention: How nurse practitioners and physician assistants can help

4.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

5.

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot